{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:13:57Z","timestamp":1790813637926,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T00:00:00Z","timestamp":1624147200000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-148413"],"award-info":[{"award-number":["FDN-148413"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MFE-135472"],"award-info":[{"award-number":["MFE-135472"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-74618"],"award-info":[{"award-number":["MOP-74618"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["255989"],"award-info":[{"award-number":["255989"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["MFE-164740"],"award-info":[{"award-number":["MFE-164740"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejphar.2020.173174","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T12:40:12Z","timestamp":1591792812000},"page":"173174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog"],"prefix":"10.1016","volume":"882","author":[{"given":"Pascal","family":"T\u00e9treault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lie","family":"Besserer-Offroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Ren\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Murza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J.","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Beaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Longpr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine","family":"Cavelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173174_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(91)90139-M","article-title":"Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem","volume":"557","author":"al-Rodhan","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib2","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.bja.2018.12.023","article-title":"Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal","volume":"122","author":"Algera","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2020.173174_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2008.06.017","article-title":"Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib","volume":"174","author":"Angeby-Moller","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2020.173174_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(84)90619-X","article-title":"A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques","volume":"324","author":"Behbehani","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib5","series-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","first-page":"87","author":"Bennett","year":"1988"},{"key":"10.1016\/j.ejphar.2020.173174_bib6","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejphar.2020.173174_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.03.046","article-title":"The signaling signature of the neurotensin type 1 receptor with endogenous ligands","author":"Besserer-Offroy","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3166\/dea-2019-0065","article-title":"Sending out biased signals: an appropriate proposition for pain?","volume":"32","author":"Besserer-Offroy","year":"2019","journal-title":"Douleur Analg\u00e9sie"},{"key":"10.1016\/j.ejphar.2020.173174_bib9","series-title":"Data Set Describing the in Vitro Biological Activity of JMV2009, a Novel Silylated Neurotensin(8-13) Analog","author":"Besserer-Offroy","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173174_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/262607a0","article-title":"Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin","author":"Bissette","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173174_bib11","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1021\/jm049644y","article-title":"Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13)","volume":"47","author":"Bittermann","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/FBP.0b013e3283474a3a","article-title":"Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine","volume":"22","author":"Boules","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2009.10.050","article-title":"NT79: a novel neurotensin analog with selective behavioral effects","author":"Boules","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)02981-X","article-title":"Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties","author":"Boules","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2009.07.086","article-title":"NT69L, a novel analgesic, shows synergy with morphine","author":"Boules","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib16","article-title":"The evolving role of long-term pharmacotherapy for opioid-induced constipation in patients being treated for noncancer pain","author":"Bowers","year":"2017","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.ejphar.2020.173174_bib17","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/jm700925k","article-title":"Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier","author":"Bredeloux","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbr.2006.09.016","article-title":"Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice","volume":"175","author":"Bredeloux","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib19","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.ejphar.2020.173174_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(83)92028-7","article-title":"Neurotensin stimulates defaecation","volume":"1","author":"Calam","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173174_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1399-3011.2004.00145.x","article-title":"Biological activity of silylated amino acid containing substance P analogues","volume":"63","author":"Cavelier","year":"2004","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/psc.767","article-title":"Conformational studies of proline-, thiaproline- and dimethylsilaproline-containing diketopiperazines","volume":"12","author":"Cavelier","year":"2006","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejphar.2020.173174_bib23","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1021\/ja017440q","article-title":"Influence of silaproline on peptide conformation and bioactivity","author":"Cavelier","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2020.173174_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpain.2005.08.001","article-title":"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study","volume":"7","author":"Chu","year":"2006","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.pain.2012.01.016","article-title":"Inflammation-induced Decrease in Voluntary Wheel Running in Mice: A Nonreflexive Test for Evaluating Inflammatory Pain and Analgesia","author":"Cobos","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1476-5381.1968.tb00973.x","article-title":"The abdominal constriction response and its suppression by analgesic drugs in the mouse","volume":"32","author":"Collier","year":"1968","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejphar.2020.173174_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pds.4366","article-title":"Opioid analgesic dose and the risk of misuse, overdose, and death: a narrative review","volume":"27","author":"Coyle","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173174_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/psc.1201","article-title":"Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme","volume":"16","author":"Dalkas","year":"2010","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejphar.2020.173174_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2012.11.011","article-title":"Opioids for chronic pain: new evidence, new strategies, safe prescribing","author":"de Leon-Casasola","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2020.173174_bib30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI70647","article-title":"Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties","volume":"124","author":"Demeule","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173174_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/JPR.S124526","article-title":"Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain","volume":"10","author":"Deseure","year":"2017","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173174_bib33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079905X65321","article-title":"Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain","author":"Devulder","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2020.173174_bib34","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.peptides.2006.04.025","article-title":"Neurotensin and pain modulation","volume":"27","author":"Dobner","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2020.173174_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(92)90314-T","article-title":"JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse","volume":"219","author":"Dubuc","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0196-9781(94)90017-5","article-title":"Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats","volume":"15","author":"Dubuc","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2020.173174_bib37","series-title":"The Formalin Test: a Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats","first-page":"161","author":"Dubuisson","year":"1977"},{"key":"10.1016\/j.ejphar.2020.173174_bib38","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm200006c","article-title":"Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics","author":"Einsiedel","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2019.01.048","article-title":"The combination of opioid and neurotensin receptor agonists improves their analgesic\/adverse effect ratio","volume":"848","author":"Eiselt","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib40","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acs.orglett.7b01172","article-title":"Hydrophobic alpha,alpha-disubstituted disilylated TESDpg induces incipient 310-helix in short tripeptide sequence","volume":"19","author":"Fanelli","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejphar.2020.173174_bib41","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.5b00841","article-title":"Synthesis and characterization in vitro and in vivo of (l)-(Trimethylsilyl)alanine containing neurotensin analogues","volume":"58","author":"Fanelli","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pbb.2004.12.005","article-title":"Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys","volume":"80","author":"Fantegrossi","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2020.173174_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2009.07.001","article-title":"The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature","volume":"58","author":"Feifel","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173174_bib44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/1381612820666141027124915","article-title":"The roles of neurotensin and its analogues in pain","volume":"21","author":"Feng","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2020.173174_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2020.173174_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuroscience.2007.01.002","article-title":"Sex differences in opioid-mediated pain inhibitory mechanisms during the interphase in the formalin test","author":"Gaumond","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173174_bib47","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1124\/mol.104.002303","article-title":"Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1\/2","volume":"66","author":"Gendron","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib48","first-page":"826","article-title":"Trends in high-dose opioid prescribing in Canada","volume":"60","author":"Gomes","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ejphar.2020.173174_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpain.2011.07.008","article-title":"Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain","author":"Guillemette","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejphar.2020.173174_bib51","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ejoc.201501495","article-title":"Stereoselective synthesis of \u03b2-(5-arylthiazolyl) \u03b1-amino acids and use in neurotensin analogues","author":"Hap\u0103u","year":"2016","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cmdc.201300054","article-title":"Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids","volume":"8","author":"Held","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejphar.2020.173174_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1748-1716.1981.tb06875.x","article-title":"Effects of neurotensin, substance P and methionine-enkephalin on colonic motility","volume":"113","author":"Hellstrom","year":"1981","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2020.173174_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-3011.1994.tb00165.x","article-title":"Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues","volume":"44","author":"Heyl","year":"1994","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib55","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1021\/jm100092s","article-title":"Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic","author":"Hughes","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2020.173174_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","article-title":"Biased receptor signaling in drug discovery","volume":"71","author":"Kenakin","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173174_bib58","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1213\/ANE.0b013e3181cde882","article-title":"The development of new analgesics over the past 50 years: a lack of real breakthrough drugs","volume":"110","author":"Kissin","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173174_bib60","first-page":"86","article-title":"PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects","author":"Kleczkowska","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2013.03.004","article-title":"Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review","volume":"716","author":"Kleczkowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib62","article-title":"Acetic acid for analgesic screening","volume":"18","author":"Koster","year":"1959","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ejphar.2020.173174_bib63","doi-asserted-by":"crossref","first-page":"38564","DOI":"10.1038\/srep38564","article-title":"Structure and dynamics of a constitutively active neurotensin receptor","volume":"6","author":"Krumm","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173174_bib64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3565(25)38482-X","article-title":"In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes","author":"Labb\u00e9-Julli\u00e9","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173174_bib65","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib66","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00726-019-02741-2","article-title":"Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids","volume":"51","author":"Magafa","year":"2019","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2020.173174_bib67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bcp.2011.10.014","article-title":"Peptide therapeutics for CNS indications","author":"McGonigle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173174_bib70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/cb900038e","article-title":"Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors","author":"Myers","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173174_bib71","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.lfs.2009.02.014","article-title":"Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats","volume":"84","author":"Nakazato-Imasato","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173174_bib72","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1073\/pnas.76.10.5368","article-title":"Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine","volume":"76","author":"Nemeroff","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173174_bib73","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3565(25)32585-1","article-title":"Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone","volume":"217","author":"Osbahr","year":"1981","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173174_bib74","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173174_bib75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0143-4179(96)90002-5","article-title":"Peripheral neurotensin participates in the modulation of pre- and postprandial intestinal motility in rats","volume":"30","author":"Pellissier","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2020.173174_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2018.10.011","article-title":"Recent progress in non-opioid analgesic peptides","volume":"660","author":"Perez de Vega","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2020.173174_bib77","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1021\/acs.chemrev.6b00122","article-title":"Silicon-containing amino acids: synthetic aspects, conformational studies, and applications to bioactive peptides","volume":"116","author":"Remond","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2020.173174_bib78","series-title":"Peptidomimetics I","first-page":"27","article-title":"Silaproline, a silicon-containing proline surrogate","author":"Remond","year":"2017"},{"key":"10.1016\/j.ejphar.2020.173174_bib79","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.109.165282","article-title":"Systemically and topically active antinociceptive neurotensin compounds","author":"Rossi","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173174_bib80","first-page":"38","article-title":"Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity","author":"Roussy","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2020.173174_bib81","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1471-4159.2007.05205.x","article-title":"Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model","author":"Roussy","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173174_bib82","series-title":"Neurotensin and its Receptors, Reference Module in Neuroscience and Biobehavioral Psychology","first-page":"1","author":"Sarret","year":"2018"},{"key":"10.1016\/j.ejphar.2020.173174_bib83","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1523\/JNEUROSCI.0810-05.2005","article-title":"Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors","author":"Sarret","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173174_bib84","first-page":"145","article-title":"The formalin test: characteristics and usefulness of the model","author":"Sawynok","year":"2004","journal-title":"Rev. Analg."},{"key":"10.1016\/j.ejphar.2020.173174_bib85","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/acs.jmedchem.8b00175","article-title":"Structural optimization and characterization of potent analgesic macrocyclic analogues of neurotensin (8-13)","volume":"61","author":"Sousbie","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib86","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1124\/mi.9.5.7","article-title":"In search of analgesia: emerging roles of GPCRs in pain","volume":"9","author":"Stone","year":"2009","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ejphar.2020.173174_bib87","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/ejn.12643","article-title":"Studying ongoing and spontaneous pain in rodents--challenges and opportunities","volume":"39","author":"Tappe-Theodor","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173174_bib88","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1096\/fj.12-225540","article-title":"Spinal NTS2 receptor activation reverses signs of neuropathic pain","volume":"27","author":"Tetreault","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2020.173174_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0016-5085(86)90070-3","article-title":"Neurotensin increases colonic motility","volume":"90","author":"Thor","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173174_bib90","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1248\/cpb.38.3094","article-title":"Stability of a novel hexapeptide, (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt, with neurotensin activity, in aqueous solution and in the solid state","volume":"38","author":"Tokumura","year":"1990","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejphar.2020.173174_bib91","first-page":"1662","article-title":"The effects of neurotensin in the colon of patients with slow transit constipation","volume":"54","author":"Tomita","year":"2007","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173174_bib92","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(98)00150-4","article-title":"Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception","volume":"792","author":"Tyler","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173174_bib93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(99)00877-8","article-title":"Highly potent neurotensin analog that causes hypothermia and antinociception","volume":"390","author":"Tyler-McMahon","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173174_bib94","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.physbeh.2011.05.015","article-title":"Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats","author":"T\u00e9treault","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2020.173174_bib95","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/(SICI)1099-0690(200003)2000:5<807::AID-EJOC807>3.0.CO;2-E","article-title":"Synthesis of silaproline, a new proline surrogate","volume":"2000","author":"Vivet","year":"2000","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejphar.2020.173174_bib96","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11558","article-title":"Structure of the agonist-bound neurotensin receptor","volume":"490","author":"White","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173174_bib97","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0960-894X(95)00155-M","article-title":"Reduced amide bond neurotensin 8-13 mimetics with potent in vivo activity","volume":"5","author":"Wustrow","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173174_bib98","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tips.2018.10.003","article-title":"Development of new analgesics: an answer to opioid epidemic","volume":"39","author":"Yaksh","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173174_bib99","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0024-3205(03)00546-0","article-title":"Antinociception induced by beta-lactotensin, a neurotensin agonist peptide derived from beta-lactoglobulin, is mediated by NT2 and D1 receptors","volume":"73","author":"Yamauchi","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173174_bib100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1476-5381.2011.01760.x","article-title":"Intrathecal neurotensin is hypotensive, sympathoinhibitory and enhances the baroreflex in anaesthetized rat","volume":"166","author":"Zogovic","year":"2012","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:08:31Z","timestamp":1762142911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":100,"alternative-id":["S0014299920302661"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173174","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173174"}}